Zebra Applied sciences (NASDAQ:ZBRA) Third Quarter 2022 Outcomes
Key Monetary Outcomes
- Income: US$1.38b (down 4.0% from 3Q 2021).
- Internet earnings: US$170.0m (down 15% from 3Q 2021).
- Revenue margin: 12% (down from 14% in 3Q 2021).
- EPS: US$3.28 (down from US$3.73 in 3Q 2021).
All figures proven within the chart above are for the trailing 12 month (TTM) interval
Zebra Applied sciences Revenues and Earnings Miss Expectations
Income missed analyst estimates by 6.8%. Earnings per share (EPS) additionally missed analyst estimates by 11%.
Trying forward, income is forecast to develop 4.8% p.a. on common through the subsequent 3 years, in comparison with a 5.9% progress forecast for the Digital business within the US.
Efficiency of the American Digital business.
The corporate’s shares are down 14% from every week in the past.
Threat Evaluation
It is nonetheless needed to contemplate the ever-present spectre of funding threat. We have recognized 4 warning indicators with Zebra Applied sciences, and understanding these ought to be a part of your funding course of.
Valuation is complicated, however we’re serving to make it easy.
Discover out whether or not Zebra Applied sciences is doubtlessly over or undervalued by testing our complete evaluation, which incorporates honest worth estimates, dangers and warnings, dividends, insider transactions and monetary well being.
View the Free Evaluation
Have suggestions on this text? Involved concerning the content material? Get in contact with us immediately. Alternatively, electronic mail editorial-team (at) simplywallst.com.
This text by Merely Wall St is common in nature. We offer commentary based mostly on historic information and analyst forecasts solely utilizing an unbiased methodology and our articles should not supposed to be monetary recommendation. It doesn’t represent a advice to purchase or promote any inventory, and doesn’t take account of your aims, or your monetary state of affairs. We goal to carry you long-term targeted evaluation pushed by basic information. Word that our evaluation might not issue within the newest price-sensitive firm bulletins or qualitative materials. Merely Wall St has no place in any shares talked about.
Supply hyperlink
